SPRY2 and hepatocellular carcinoma: We also analyzed the correlation of SPRY2 expression with HCC patients’ survival, results showed that low SPRY2 expression was associated with poorer OS and DFS (P < 0.01, respectively), which was consistent with high miR-330-5p in HCC (Fig. 4g).